Literature DB >> 11336374

Disability under Social Security for patients with ESRD: an evidence-based review.

K Tappe1, C Turkelson, D Doggett, V Coates.   

Abstract

PURPOSE: In the United States, all individuals with end-stage renal (ESRD) disease are automatically eligible for disability benefits under the Social Security Act. Recently, there have been questions about whether the diagnosis of ESRD alone is an appropriate criterion for determining disability under Social Security.
METHODS: We conducted a systematic review of the published literature and de novo analysis of data from the United States Renal Data System (USRDS) in an attempt to identify the best predictors of inability to work that might be useful during the disability determination process.
RESULTS: The published literature yielded little relevant evidence. The USRDS provided a prospectively-collected set of data on 4,026 incident dialysis patients over their first year on dialysis, a time period particularly applicable to the key questions. However. data from over half of the patients were missing for the most important variables to this project, and only 42% of patients completed the one-year follow-up questionnaire. These limitations rendered de novo analyses unreliable. However, summary statistics did reveal a decreasing number of working individuals over time, from 41.9% before the initiation of dialysis. to 21.1% at initiation, and 6.6% a year later.

Entities:  

Mesh:

Year:  2001        PMID: 11336374     DOI: 10.1080/09638280151080522

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  2 in total

1.  Prognostic factors for work ability in sicklisted employees with chronic diseases.

Authors:  F G Slebus; P P F M Kuijer; J Han H B M Willems; J K Sluiter; M H W Frings-Dresen
Journal:  Occup Environ Med       Date:  2007-05-23       Impact factor: 4.402

2.  A Matter of Choice: Opportunities and Obstacles Facing People with ESRD.

Authors:  Judith Feder; Mark V Nadel; Mahesh Krishnan
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-09       Impact factor: 8.237

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.